IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roudy who wrote (1178)	7/29/1997 4:34:00 PM
From: Rick Costantino	of 1762

Don, I concur with you. All I say is it will pay to be patient. There may be some issues over when C2B8 will get final market clearance and what the market size will be. All I can say here is that, even with good marketing, it is somewhat difficult to accurately predict the market for a given drug. Even large, established biotechs are often over or under the real value. Also, it looks like Y2B8 will also be a good clinical candidate for treating NHL, and they are a few other molecules in the pre-clinical works. And they also said there may be another generation CE9.1 to put in Phase II for RA. Now would be a good time for some other news on any of these to come out, as IDPH has stabilized at a fairly high level. Do you think we will see any lower movement, some even were looking for "the high teens". I don't think so. If it happens, I will accumulate big time. More likely, IDPH should move back up a bit, once the profit-takers are gone, to aroun $27-30. With market clearance at some point, and with maybe another good piece of news or so, we should see higher by year's end. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next